Docket Number: FDA-2020-D-2307 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Oncology Center of Excellence The Food […]

Talking with Capt. Martin Shimer, the former Deputy Director of the Division of Legal and Program Support, Office of Generic Drugs, CDER. The FDA’s publication Approved […]

For Immediate Release: July 23, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, […]

Product: Drugs Recipient: V10Suppliers.com United Kingdom Issuing Office: Center for Drug Evaluation and Research (CDER) United States FROM: The United States Food and Drug Administration RE: […]

Docket Number: FDA-2022-D-0112 Issued by: Guidance Issuing Office Office of the Commissioner, Office of Clinical Policy and Programs, Office of Pediatric Therapeutics Center for Drug Evaluation […]

Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. Uday Chile Recipient Title Director Brassica Pharma Pvt. Ltd. 301, Soni Palace, Haridas NagarNear Hero […]

Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Ms. Gloria J. Vanderlaan Recipient Title Chief Executive Officer Genuine Virgin Aloe Corp dba Triderma […]

Delivery Method: VIA EMAIL WITH READ RECEIPT Product: Drugs Recipient: Recipient Name Mr. Hsu Ke Fu Recipient Title Factory Manager Yahon Enterprise Co., Ltd. An Chu […]

FOR IMMEDIATE RELEASEMonday, July 22, 2024 London, United Kingdom – The United States Food and Drug Administration (FDA) Office of Criminal Investigations (OCI) successfully executed Operation […]